Related changes
← Tutorial
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
2 June 2024
|
|
02:18 | Eligibility criteria 2 changes history +2,309 [Warner-admin (2×)] | |||
|
|
02:18 (cur | prev) +281 Warner-admin talk contribs | ||||
|
|
02:17 (cur | prev) +2,028 Warner-admin talk contribs →Real-world data (RWD) (new for 2024) | ||||
1 June 2024
|
|
12:20 | Main Page 3 changes history +18 [Warner-admin (3×)] | |||
|
|
12:20 (cur | prev) -28 Warner-admin talk contribs | ||||
|
|
12:17 (cur | prev) 0 Warner-admin talk contribs | ||||
| m |
|
12:16 (cur | prev) +46 Warner-admin talk contribs | |||
| 12:18 | Eligibility criteria diffhist +15 Warner-admin talk contribs →Background | ||||
|
|
m 12:18 | Philosophy 3 changes history +270 [Jwarner (3×)] | |||
| m |
|
12:18 (cur | prev) +126 Jwarner talk contribs →HemOnc.org Overarching Goals | |||
| m |
|
12:17 (cur | prev) +1 Jwarner talk contribs →HemOnc.org Overarching Goals | |||
| m |
|
12:17 (cur | prev) +143 Jwarner talk contribs | |||
| 03:36 | Mantle cell lymphoma diffhist +1,367 Jwarner talk contribs →Obinutuzumab monotherapy {{#subobject:7f1090|Regimen=1}} | ||||
30 May 2024
|
|
m 23:32 | Breast cancer 2 changes history -33 [Warner-admin (2×)] | |||
| m |
|
23:32 (cur | prev) -1 Warner-admin talk contribs Text replacement - "Mitomycine" to "Mitomycin" | |||
| m |
|
23:12 (cur | prev) -32 Warner-admin talk contribs | |||
|
|
23:22 | Diffuse large B-cell lymphoma 2 changes history +209 [Warner-admin; Jwarner] | |||
|
|
23:22 (cur | prev) +9 Warner-admin talk contribs | ||||
| m |
|
14:13 (cur | prev) +200 Jwarner talk contribs | |||
| 19:11 | Main Page diffhist +116 Warner-admin talk contribs | ||||
|
|
m 14:27 | Drug index 2 changes history +37 [Jwarner (2×)] | |||
| m |
|
14:27 (cur | prev) +11 Jwarner talk contribs →Supportive and other medications | |||
| m |
|
14:26 (cur | prev) +26 Jwarner talk contribs →R | |||
28 May 2024
|
|
19:46 | Mantle cell lymphoma 4 changes history +13,776 [Jwarner (4×)] | |||
|
|
19:46 (cur | prev) +8,011 Jwarner talk contribs →R-CHOP {{#subobject:ca52ab|Regimen=1}} | ||||
| m |
|
19:40 (cur | prev) +136 Jwarner talk contribs →R-CHOP/R-DHAP {{#subobject:989434|Regimen=1}} | |||
| m |
|
19:39 (cur | prev) +137 Jwarner talk contribs →R-CHOP/R-DHAOx {{#subobject:98ox34|Regimen=1}} | |||
|
|
19:36 (cur | prev) +5,492 Jwarner talk contribs →R-CHOP/R-DHAP {{#subobject:989434|Regimen=1}} | ||||
|
|
14:28 | Editorial Board 2 changes history -1,225 [Warner-admin (2×)] | |||
|
|
14:28 (cur | prev) -316 Warner-admin talk contribs →COI Disclosures | ||||
|
|
14:28 (cur | prev) -909 Warner-admin talk contribs | ||||
| m 13:49 | Multiple myeloma diffhist +170 Jwarner talk contribs →BSH/UKMF | ||||
|
|
m 12:52 | Breast cancer, HER2-positive 4 changes history +2,848 [Jwarner (4×)] | |||
| m |
|
12:52 (cur | prev) +16 Jwarner talk contribs | |||
| m |
|
12:51 (cur | prev) +1,138 Jwarner talk contribs | |||
| m |
|
12:06 (cur | prev) +585 Jwarner talk contribs →References | |||
| m |
|
12:05 (cur | prev) +1,109 Jwarner talk contribs →Paclitaxel & Trastuzumab (TH) {{#subobject:aa22dd|Regimen=1}} | |||
27 May 2024
|
|
m 13:59 | Breast cancer, HER2-positive 2 changes history +4,127 [Jwarner (2×)] | |||
| m |
|
13:59 (cur | prev) +1,833 Jwarner talk contribs →Paclitaxel & Trastuzumab (TH) {{#subobject:aa22dd|Regimen=1}} | |||
| m |
|
13:14 (cur | prev) +2,294 Jwarner talk contribs →TH-FEC & H (Docetaxel) {{#subobject:d2476f|Regimen=1}} | |||
25 May 2024
| m 15:43 | Therapeutic equivalents diffhist +33 Jwarner talk contribs →Biosimilars | ||||
| m 15:42 | Drug index diffhist +32 Jwarner talk contribs →B | ||||
| m 11:09 | Complex multipart regimens diffhist -1,458 Jwarner talk contribs →PRONOUNCE | ||||
| 02:45 | Breast cancer, HER2-positive diffhist +2,114 Jwarner talk contribs →TCHP (Paclitaxel) {{#subobject:ab8cj1|Regimen=1}} | ||||
| m 02:27 | Diffuse large B-cell lymphoma diffhist +180 Jwarner talk contribs | ||||
24 May 2024
|
|
m 13:43 | Breast cancer 6 changes history -18,104 [Jwarner (6×)] | |||
| m |
|
13:43 (cur | prev) 0 Jwarner talk contribs →Metastatic disease, first-line chemotherapy | |||
| m |
|
13:41 (cur | prev) +148 Jwarner talk contribs →Adjuvant chemotherapy | |||
| m |
|
13:40 (cur | prev) +96 Jwarner talk contribs →Adjuvant therapy, sequential regimens | |||
| m |
|
13:30 (cur | prev) +1,190 Jwarner talk contribs →FEC {{#subobject:3613b7|Regimen=1}} | |||
| m |
|
13:24 (cur | prev) -19,616 Jwarner talk contribs →Cyclophosphamide & Doxorubicin (AC) {{#subobject:77b0fd|Regimen=1}} | |||
| m |
|
11:21 (cur | prev) +78 Jwarner talk contribs →References | |||
| m 13:01 | Therapeutic equivalents diffhist +184 Jwarner talk contribs →Biosimilars | ||||
|
|
m 12:57 | Drug index 2 changes history +243 [Jwarner (2×)] | |||
| m |
|
12:57 (cur | prev) +179 Jwarner talk contribs →Approved antineoplastics | |||
| m |
|
12:38 (cur | prev) +64 Jwarner talk contribs →T | |||
|
|
m 12:51 | Breast cancer, HER2-positive 3 changes history +6,249 [Jwarner (3×)] | |||
| m |
|
12:51 (cur | prev) +1,056 Jwarner talk contribs →Docetaxel & Trastuzumab (TH) {{#subobject:c99645|Regimen=1}} | |||
| m |
|
12:25 (cur | prev) +3,245 Jwarner talk contribs →Paclitaxel & Trastuzumab (TH) {{#subobject:aa22dd|Regimen=1}} | |||
| m |
|
12:20 (cur | prev) +1,948 Jwarner talk contribs →Docetaxel & Trastuzumab (TH) {{#subobject:c99645|Regimen=1}} | |||
23 May 2024
| m 12:57 | Mantle cell lymphoma diffhist +676 Jwarner talk contribs →Bendamustine & Rituximab (BR) {{#subobject:b7779c|Regimen=1}} | ||||
| m 12:06 | Breast cancer diffhist +3,930 Jwarner talk contribs | ||||